Vascular Biogenics Ltd. (NASDAQ:VBLT) went up by 12.30% from its latest closing price compared to the recent 1-year high of $2.20. The company’s stock price has collected 10.19% of gains in the last five trading sessions.
Is It Worth Investing in Vascular Biogenics Ltd. (NASDAQ :VBLT) Right Now?
Plus, the 36-month beta value for VBLT is at 0.75. Opinions of the stock are interesting as 0 analysts out of 1 who provided ratings for Vascular Biogenics Ltd. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $5.00, which is $4.84 above the current price. VBLT currently public float of 53.36M and currently shorts hold a 0.11% ratio of that float. Today, the average trading volume of VBLT was 1.27M shares.
VBLT’s Market Performance
VBLT stocks went up by 10.19% for the week, with a monthly jump of 38.05% and a quarterly performance of 17.27%, while its annual performance rate touched -89.55%. The volatility ratio for the week stands at 8.58% while the volatility levels for the past 30 days are set at 10.23% for Vascular Biogenics Ltd. The simple moving average for the period of the last 20 days is 19.46% for VBLT stocks with a simple moving average of -77.32% for the last 200 days.
Analysts’ Opinion of VBLT
Oppenheimer gave a rating of “Outperform” to VBLT, setting the target price at $5.50 in the report published on July 18th of the previous year.
VBLT Trading at 19.31% from the 50-Day Moving Average
After a stumble in the market that brought VBLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.78% of loss for the given period.
Volatility was left at 10.23%, however, over the last 30 days, the volatility rate increased by 8.58%, as shares surge +44.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +29.29% upper at present.
During the last 5 trading sessions, VBLT rose by +10.19%, which changed the moving average for the period of 200-days by -90.82% in comparison to the 20-day moving average, which settled at $0.1355. In addition, Vascular Biogenics Ltd. saw 32.42% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for VBLT
Current profitability levels for the company are sitting at:
- -3905.73 for the present operating margin
- -111.07 for the gross margin
The net margin for Vascular Biogenics Ltd. stands at -3895.83. Equity return is now at value -98.60, with -75.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 5.53.